Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Questions Remain About Abatacept Lupus Trial
Link ID 29973
Title Questions Remain About Abatacept Lupus Trial
Url http://www.medscape.com/viewarticle/730936?src=rss
Description Abatacept did not prevent lupus flares in non-life-threatening SLE, but trial design problems might have obscured efficacy. Medscape Medical News
Category Articles > Rheumatology
Keywords
Date Oct 21, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. The Value of Synovial Cytokine Expression in Predicting the Clinical Response to TNF Antagonist Ther
  Few studies have investigated the basis for the difference in clinical response to TNF-alpha blockade therapy. Can pre-treatment synovial TNF-alpha or IL-1 expression predict TNF blockade response?
Rheumatology
Category:   Articles > Rheumatology


2. Quality of Care in the Rheumatic Diseases: Current Status and Future Directions
  The authors review the recent literature examining quality of care for several prevalent rheumatic conditions, including rheumatoid arthritis, osteoarthritis, gout and osteoporosis, and summarize quality measurement and improvement initiatives relevant to rheumatology.
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


3. Possible Environmental Determinants of Juvenile Idiopathic Arthritis
  What is currently known about environmental risk factors for the development of juvenile idiopathic arthritis? Rheumatology
Category:   Articles > Rheumatology


4. TNF Antagonists Not Linked to Major Malignant Lymphoma Risk in RA Patients
  Anti-tumor necrosis factor (TNF) therapy does not markedly increase the risk of malignant lymphoma in patients with rheumatoid arthritis, according to the results of a Swedish study. This study is one of the largest to-date to assess effects of anti-TNF therapy in rheumatoid arthritis patients. Reuters Health Information
Category:   Articles > Rheumatology


5. Infliximab Improves Symptoms of Ankylosing Spondylitis, but Damage Continues
  In patients with ankylosing spondylitis, infliximab does not inhibit structural damage, although it may have other beneficial effects, according to European and US researchers. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS